Results 101 to 110 of about 5,575,329 (338)

PSA LEVEL AND ADVERSE EVENTS IN SIXTH AND TENTH SERIES DOCETAXEL CHEMOTHERAPY IN CASTRATE-RESISTANT PROSTATE CANCER (CRPC) PATIENTS

open access: yesJurnal Urologi Indonesia
Objective: This study aims to compare the efficacy of docetaxel on PSA levels and to analyze the adverse events caused by docetaxel. Material & Methods: The study design was retrospective cohort.
Kurnia Penta Seputra   +2 more
doaj   +1 more source

Adverse events related to blood transfusion

open access: yesIndian Journal of Anaesthesia, 2014
The acute blood transfusion reactions are responsible for causing most serious adverse events. Awareness about various clinical features of acute and delayed transfusion reactions with an ability to assess the serious reactions on time can lead to a ...
Sandeep Sahu, Hemlata, Anupam Verma
doaj   +1 more source

A systematic review of adverse events in randomized trials assessing immune checkpoint inhibitors

open access: yesInternational Journal of Cancer, 2019
The advent of immune checkpoint‐inhibitors (CPI) has transformed treatment for several cancer types. This review was performed to assess the rate of adverse events (AEs) associated with the use of CPI, alone or in combinations.
P. Arnaud-Coffin   +6 more
semanticscholar   +1 more source

Understanding and Responding to Adverse Events

open access: yesNew England Journal of Medicine, 2003
This article describes a method of investigating and learning from adverse events. Careful investigation and systems analysis can identify the factors that set the stage for a medical error. The author argues that the process of understanding adverse events leads to improvements in care and reductions in errors and that insensitive and inadequate ...
openaire   +4 more sources

Serum Neurofilament Light Chain in Multiple Sclerosis: Superiority of Age‐ and BMI‐Corrected Z Scores/Percentiles Over Absolute Cutoff Values for Prediction of Treatment Response

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Prognostication of disease course and prediction of treatment response in multiple sclerosis is an unmet need. We compared the performance of serum neurofilament light chain Z scores (age‐ and BMI‐adjusted) with absolute concentrations for the prediction of response to disease‐modifying therapy.
Maximilian Einsiedler   +43 more
wiley   +1 more source

Postmarketing Surveillance of Full Spectrum Hemp Extract CBD Products: Reported Adverse Events and Serious Adverse Events

open access: yesDrugs - Real World Outcomes
Background There is a growing interest in products featuring hemp extracts and a demand for more data regarding their safety. To date, there is a paucity of published data on the safety of these products. Methods A retrospective analysis of postmarketing
Colleen M. Kingsbury   +2 more
doaj   +1 more source

Adverse Events During Invasive EEG Recordings

open access: yesPediatric Neurology Briefs, 2011
Researchers in the Department of Paediatric Neurosurgery and Epilepsy Unit, Great Ormond Street Hospital, London, UK analyzed the hospital charts of 95 children operated on between 1995 and 2009 for medication-resistant focal epilepsy and requiring ...
J Gordon Millichap
doaj   +1 more source

Translating a Preclinically Tested 15 Hz rTMS Protocol to Humans With Chronic Spinal Cord Injury: A Safety and Feasibility Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives Repetitive transcranial magnetic stimulation (rTMS) is a non‐invasive brain stimulation strategy with a demonstrated potential to reinforce the residual pathways after a spinal cord injury (SCI). A preclinically tested high‐frequency (15 Hz) rTMS (15 Hz rTMS) protocol was shown to induce corticospinal tract axon regeneration growth ...
Nabila Brihmat   +8 more
wiley   +1 more source

Immune-related adverse events of checkpoint inhibitors

open access: yesNature Reviews Disease Primers, 2020
M. Ramos-Casals   +9 more
semanticscholar   +2 more sources

Home - About - Disclaimer - Privacy